Get the Stockscreener App
0.535
0.79%
0.0042
After Hours:
.62
0.085
+15.89%
Painreform Ltd stock is traded at $0.535, with a volume of 127.53K.
It is up +0.79% in the last 24 hours and down -18.94% over the past month.
See More
Previous Close:
$0.5308
Open:
$0.5355
24h Volume:
127.53K
Relative Volume:
0.27
Market Cap:
$703.80K
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.0589
EPS:
-9.0833
Net Cash Flow:
$-6.69M
1W Performance:
-5.31%
1M Performance:
-18.94%
6M Performance:
-89.45%
1Y Performance:
-95.81%
1-Day Range:
$0.511
$0.55
1-Week Range:
$0.5054
$0.627
52-Week Range:
$0.4318
$20.16
Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| PRFX | 0.535 | 703.80K | 0 | -9.34M | -6.69M | -9.0833 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Painreform Ltd Stock (PRFX) Latest News
PainReform Announces 1-for-4 Reverse Share Split - TipRanks
Armistice Capital, LLC's Strategic Acquisition in PainReform Ltd - GuruFocus.com
PainReform faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
PainReform receives Nasdaq notice regarding minimum stockholders’ equity requirement - MSN
PRFXPainReform Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
PainReform faces Nasdaq delisting over equity shortfall - Investing.com India
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement - GlobeNewswire
PRFX stock touches 52-week low at $0.53 amid sharp annual decline - Investing.com India
PainReform cut to Hold at Maxim amid ‘changed’ market dynamics - Yahoo Finance
Maxim cuts PainReform stock rating to Hold from Buy post FDA update - Investing.com India
Maxim cuts PainReform stock rating to Hold from Buy post FDA update By Investing.com - Investing.com South Africa
PainReform (NASDAQ:PRFX) Shares Up 11% – Here’s Why - Defense World
PainReform Announces Significant Share Offering - TipRanks
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
What You Didn’t Know About PainReform Ltd (NASDAQ: PRFX) This Week - Stocks Register
When Would Be The Best Time To Buy SBA Communications Corp (NASDAQ: SBAC) Stock? - Stocks Register
What You Didn’t Know About Crown Castle Inc (NYSE: CCI) This Week - Stocks Register
PainReform Calls Shareholder Meeting for Key Votes - TipRanks
PainReform Shareholders Approve All Proposals - TipRanks
Prestige Wealth Inc. (NASDAQ:PWM) Sees Significant Drop in Short Interest - Defense World
PainReform Ltd. (NASDAQ:PRFX) Short Interest Up 2,221.4% in September - Defense World
Insider’s View: Deciphering PainReform Ltd (PRFX)’s Financial Health Through Ratios - The Dwinnex
US Stocks Edge Higher; Chicago Fed National Activity Increases In August - Benzinga
PainReform Ltd (PRFX)’s results reveal risk - US Post News
Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
PainReform Ltd [PRFX] Is Currently 4.40 below its 200 Period Moving Avg: What Does This Mean? - The DBT News
Was there any good news for PainReform Ltd (PRFX) stock in the last session? - US Post News
Navigating PRFX’s Stock Market Maze: Ups and Downs in 2023 - The InvestChronicle
PRFX stock touches 52-week low at $0.74 amid sharp annual decline - Investing.com
Financial Health Check: Examining PainReform Ltd (PRFX)’s Key Ratios - The Dwinnex
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110 - GlobeNewswire
PainReform Ltd. Launches Warrant Exercise Incentive Program - TipRanks
PainReform confirms sutures compatibility for in trial for PRF-110 - TipRanks
Ratio Analysis: Unpacking PainReform Ltd (PRFX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
PainReform to issue new warrants in stock exercise deal By Investing.com - Investing.com Australia
PRFX stock touches 52-week low at $1.17 amid steep annual decline - Investing.com India
PainReform Shares Are Trading Lower Today: What's Going On - Benzinga
PainReform to issue new warrants in stock exercise deal - Investing.com
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds - GlobeNewswire
Holdings of PainReform Ltd (PRFX) are aligned with the stars - SETE News
PainReform Ltd [PRFX] is -90.64% lower this YTD. Is it still time to buy? - The DBT News
Upcoming Stock Splits This Week (September 9 to September 13) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News
PainReform Ltd: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
PainReform Ltd (PRFX) stock analysis: A simple moving average approach - US Post News
Upcoming Stock Splits This Week (September 9 to September 13) – Stay Invested - Nasdaq
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):